Regulatory mechanisms involving the transcription factor FOXP4 have been shown to modulate PTK7, contributing to the malignant progression of ovarian cancer, though the specifics of downstream signaling regulation remain uncertain. The gene discussed is FOXP4; the disease is ovarian cancer.